101 related articles for article (PubMed ID: 20822639)
1. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
Boulle A; Clayden P; Cohen K; Cohen T; Conradie F; Dong K; Geffen N; Grimwood A; Hurtado R; Kenyon C; Lawn S; Maartens G; Meintjes G; Mendelson M; Murray M; Rangaka M; Sanne I; Spencer D; Taljaard J; Variava E; Venter WD; Wilson D
S Afr Med J; 2010 Sep; 100(9):566, 568, 570-1. PubMed ID: 20822639
[No Abstract] [Full Text] [Related]
2. Integration of antiretroviral therapy with tuberculosis treatment.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
[TBL] [Abstract][Full Text] [Related]
3. Treatment. Individual approach needed for co-infections.
AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
[No Abstract] [Full Text] [Related]
4. Trial finds simultaneous HIV/tuberculosis treatment beneficial.
Baleta A
Lancet Infect Dis; 2008 Nov; 8(11):669. PubMed ID: 18992400
[No Abstract] [Full Text] [Related]
5. Timing of antiretroviral drugs during tuberculosis therapy.
Garcia-Vidal C; Salvado M; Salavert M
N Engl J Med; 2010 Jun; 362(22):2137-8; author reply 2138-9. PubMed ID: 20527080
[No Abstract] [Full Text] [Related]
6. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
von der Maase S; Gerstoft J; Wejse C
Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
[TBL] [Abstract][Full Text] [Related]
7. Timing of antiretroviral drugs during tuberculosis therapy.
Kadhiravan T
N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
[No Abstract] [Full Text] [Related]
8. Timing of antiretroviral drugs during tuberculosis therapy.
Wilson D; Meintjes G
N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
[No Abstract] [Full Text] [Related]
9. Should we be initiating antiretroviral therapy earlier? An argument in favour.
Wood R
S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
[No Abstract] [Full Text] [Related]
10. Management of tuberculosis in HIV-infected patients.
Curran A; Falcó V; Pahissa A; Ribera E
AIDS Rev; 2012; 14(4):231-46. PubMed ID: 23258298
[TBL] [Abstract][Full Text] [Related]
11. Reducing mortality from HIV infection and tuberculosis.
Koole O; Colebunders R
Lancet Infect Dis; 2011 Jul; 11(7):494-5. PubMed ID: 21514235
[No Abstract] [Full Text] [Related]
12. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
[TBL] [Abstract][Full Text] [Related]
13. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
Abdool Karim Q; Abdool Karim SS; Baxter C; Friedland G; Gengiah T; Gray A; Grobler A; Naidoo K; Padayatchi N; El-Sadr W
S Afr Med J; 2010 Dec; 100(12):808-9. PubMed ID: 21414268
[No Abstract] [Full Text] [Related]
14. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
[TBL] [Abstract][Full Text] [Related]
15. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs.
Davies MA; Meintjes G
Clin Infect Dis; 2009 Sep; 49(6):973-5. PubMed ID: 19673616
[No Abstract] [Full Text] [Related]
16. When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa?
Lawn SD; Wood R
S Afr Med J; 2007 Jun; 97(6):412, 414-5. PubMed ID: 17691468
[No Abstract] [Full Text] [Related]
17. Early versus deferred antiretroviral therapy for HIV.
Hernán MA; Robins JM
N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
[No Abstract] [Full Text] [Related]
18. Early versus deferred antiretroviral therapy for HIV.
Buchbinder SP; Jain V
N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
[No Abstract] [Full Text] [Related]
19. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
[TBL] [Abstract][Full Text] [Related]
20. Leprosy and HIV, where are we at?
Lockwood DN; Lambert SM
Lepr Rev; 2010 Sep; 81(3):169-75. PubMed ID: 21067057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
